Listen to The Lancet

A once-monthly treatment for opioid use disorder

02.18.2019 - By The LancetPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Mark Greenwald discusses buprenorphine extended release—a once-monthly injected formulation for the treatment of opioid use disorder recently approved by the US FDA.

More episodes from Listen to The Lancet